Alendronate improves QOL of postmenopausal women with osteoporosis

PURPOSE: Postmenopausal osteoporosis causes bone fracture as well as pain, physical, psychological and socially adverse effects, which affects a patient’s quality of life (QOL). The effect of alendronate on QOL was investigated compared with that of alfacalcidol in post-menopausal osteoporotic women...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kawate, Hisaya, Ohnaka, Keizo, Adachi, Masahiro, Kono, Suminori, Ikematsu, Hideyuki, Matsuo, Hisashi, Higuchi, Kazumi, Takayama, Takehiko, Takayanagi, Ryoichi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Dove Medical Press 2010
Θέματα:
Original Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861847/
https://ncbi.nlm.nih.gov/pubmed/20458350
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια